Recently, we have demonstrated that NGFR and PHLDB3, which are overexpressed in melanoma, neuroblastoma, colorectal cancer and lung cancer, can bind to MDM2 and/or p53, leading to forced inactivation of p53 and chemoresistance of cancer cells [45,46]. This evidence concerns the gene MDM2 and cancer.